RENAL-LIMITED THROMBOTIC MICROANGIOPATHY

RENAL-LIMITED THROMBOTIC MICROANGIOPATHY was reported 230 times

RENAL-LIMITED THROMBOTIC MICROANGIOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 25 0.0012
1 Endoglycosidase [EPC] 2 0.0011
2 Selective T Cell Costimulation Blocker [EPC] 5 0.0011
3 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 3 0.0005
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 54 0.0003
5 Radioligand Therapeutic Agent [EPC] 4 0.0003
6 CD52-directed Cytolytic Antibody [EPC] 5 0.0003
7 Androgen [EPC] 7 0.0003
8 SLAMF7-directed Immunostimulatory Antibody [EPC] 1 0.0002
9 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
10 Programmed Death Receptor-1 Blocking Antibody [EPC] 15 0.0002
11 Thrombopoietin Receptor Agonist [EPC] 2 0.0001
12 Topoisomerase Inhibitor [EPC] 9 0.0001
13 Vitamin K [EPC] 1 0.0001
14 Calcineurin Inhibitor Immunosuppressant [EPC] 15 0.0001
15 Alkylating Drug [EPC] 28 0.0001
16 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
17 Complement Inhibitor [EPC] 6 0.0001
18 Angiotensin Converting Enzyme Inhibitor [EPC] 13 0.0001
19 Human Immunoglobulin G [EPC] 2 0.0001
20 Kinase Inhibitor [EPC] 41 0.0001
21 Microtubule Inhibitor [EPC] 12 0.0001
22 Platinum-based Drug [EPC] 19 0.0001
23 Janus Kinase Inhibitor [EPC] 11 0.0001
24 Oxazolidinone Antibacterial [EPC] 2 0.0001
25 Dihydropyridine Calcium Channel Blocker [EPC] 21 0.0001
26 Proteasome Inhibitor [EPC] 7 0.0001
27 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0001
28 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0001
29 Erythropoiesis-stimulating Agent [EPC] 3 0.0001
30 Purine Antimetabolite [EPC] 5 0.0001
31 Thiazide-like Diuretic [EPC] 2 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 13 0.0000
33 Aldosterone Antagonist [EPC] 6 0.0000
34 Corticosteroid [EPC] 49 0.0000
35 BCL-2 Inhibitor [EPC] 2 0.0000
36 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
37 Penem Antibacterial [EPC] 1 0.0000
38 Nucleoside Metabolic Inhibitor [EPC] 8 0.0000
39 HER2/neu Receptor Antagonist [EPC] 2 0.0000
40 Fluoroquinolone Antibacterial [EPC] 3 0.0000
41 Angiotensin 2 Receptor Blocker [EPC] 7 0.0000
42 Dietary Cholesterol Absorption Inhibitor [EPC] 2 0.0000
43 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
44 Platelet Aggregation Inhibitor [EPC] 11 0.0000
45 Thiazide Diuretic [EPC] 3 0.0000
46 Androgen Receptor Inhibitor [EPC] 1 0.0000
47 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
48 Thalidomide Analog [EPC] 6 0.0000
49 Opioid Agonist [EPC] 3 0.0000
50 Loop Diuretic [EPC] 5 0.0000
51 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
52 Proton Pump Inhibitor [EPC] 5 0.0000
53 Nonsteroidal Anti-inflammatory Drug [EPC] 11 0.0000
54 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
55 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
56 Leukocyte Growth Factor [EPC] 1 0.0000
57 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
58 Interferon beta [EPC] 1 0.0000
59 Insulin Analog [EPC] 2 0.0000
60 Osmotic Laxative [EPC] 1 0.0000
61 Tumor Necrosis Factor Blocker [EPC] 2 0.0000